Early initiation of riluzole may improve absolute survival in amyotrophic lateral sclerosis

INTRODUCTION/AIMS: Riluzole improves survival in amyotrophic lateral sclerosis (ALS), but optimal time and duration of treatment are unknown. The aim of this study was to examine if timing of riluzole initiation and duration of treatment modified its effect on survival. METHODS: Patients from the PR...

Descripción completa

Detalles Bibliográficos
Autores principales: Thakore, Nimish J., Lapin, Brittany R., Mitsumoto, Hiroshi, Pooled Resource Open‐Access ALS Clinical Trials Consortium
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Clinical Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828202/
https://www.ncbi.nlm.nih.gov/pubmed/36117390
http://dx.doi.org/10.1002/mus.27724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828202/
https://www.ncbi.nlm.nih.gov/pubmed/36117390
http://dx.doi.org/10.1002/mus.27724

Ejemplares similares